Free tool

Cell therapy stocks

We cover 16 companies grouped under the Cell therapy theme. The median market value in the group is $43.21M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −71.3% to +1.5% across the middle 80 percent of the group, with a median of −27.0%.

Other lists in this group

Table

16 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
MSB.AXMesoblast Limited$2.30BMid cap+12.84%
7776.TCellSeed Inc.$57.40MMicro cap−47.75%
4896.TK Pharma,Inc.$56.46MMicro cap+15.50%
4584.TKidswell Bio Corporation$56.31MMicro cap−29.02%
ALA.AXArovella Therapeutics Limited$53.07MMicro cap−29.89%
7096.TStemCell Institute Inc.$47.97MMicro cap−20.83%
2370.TMEDINET Co., Ltd.$45.96MMicro cap−31.58%
3750.TADR Biomedical Holdings Inc.$43.76MMicro cap−14.54%
4880.TCellSource Co., Ltd.$42.67MMicro cap−43.02%
4893.TNoile-Immune Biotech Inc.$40.26MMicro cap−18.68%
4892.TCyfuse Biomedical K.K.$35.91MMicro cap−9.90%
311A.TNPT Co Ltd$20.78MMicro cap−43.33%
CMB.AXCambium Bio Limited$8.90MMicro cap−10.64%
1AD.AXAdAlta Limited$6.94MMicro cap−25.00%
CYP.AXCynata Therapeutics Limited$1.93MMicro cap−94.76%
CHM.AXChimeric Therapeutics Limited$458.81KMicro cap−96.67%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse